Formulation design and optimization of novel soft glycerosomes for enhanced topical delivery of celecoxib and cupferron by Box–Behnken statistical design

References

• Margulis-Goshen K, Kesselman E, Danino D, et al. Formation of celecoxib nanoparticles from volatile microemulsions. Int J Pharm. 2010;393:231–238.
   Web of Science ®Google Scholar
• Dolenc A, Kristl J, Baumgartner S, et al. Advantages of celecoxib nanosuspension formulation and transformation into tablets. Int J Pharm. 2009;376:204–212.
   PubMed Web of Science ®Google Scholar
• Primo FT, Froehlich P. Celecoxib identification methods. Acta Farm Bonaer. 2005;24:421.
   Google Scholar
• Ibrahim MM, Abd-Elgawad A-EH, Soliman OA-E, et al. Stability and ocular pharmacokinetics of celecoxib-loaded nanoparticles topical ophthalmic formulations. J Pharm Sci. 2016;105:3691–3701.
   PubMed Web of Science ®Google Scholar
• Homayouni A, Sadeghi F, Varshosaz J, et al. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP. Eur J Pharm Biopharm. 2014;88:261–274.
   PubMed Web of Science ®Google Scholar
• Karade P. Formulation and evaluation of celecoxib gel. J Drug Delivery Ther. 2012;2:132–135.
   Google Scholar
• Park E-S, Chang S-Y, Hahn M, et al. Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen. Int J Pharm. 2000;209:109–119.
   PubMed Web of Science ®Google Scholar
• Abdellatif KR, Chowdhury MA, Velázquez CA, et al. Celecoxib prodrugs possessing a diazen-1-ium-1, 2-diolate nitric oxide donor moiety: synthesis, biological evaluation and nitric oxide release studies. Bioorg Med Chem Lett. 2010;20:4544–4549.
   PubMed Web of Science ®Google Scholar
• Abdellatif KR, Chowdhury MA, Dong Y, et al. Diazen-1-ium-1, 2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studies. Bioorg Med Chem. 2008;16:9694–9698.
   PubMed Web of Science ®Google Scholar
• Manca ML, Cencetti C, Matricardi P, et al. Glycerosomes: use of hydrogenated soy phosphatidylcholine mixture and its effect on vesicle features and diclofenac skin penetration. Int J Pharm. 2016;511:198–204.
   PubMed Web of Science ®Google Scholar
• Manca ML, Zaru M, Manconi M, et al. Glycerosomes: a new tool for effective dermal and transdermal drug delivery. Int J Pharm. 2013;455:66–74.
   PubMed Web of Science ®Google Scholar
• Fetih G, Fathalla D, El‐Badry M. Liposomal gels for site-specific, sustained delivery of celecoxib: in vitro and in vivo evaluation. Drug Dev Res. 2014;75:257–266.
   PubMed Web of Science ®Google Scholar
• Agyralides GG, Dallas PP, Rekkas DM. Development and in vitro evaluation of furosemide transdermal formulations using experimental design techniques. Int J Pharm. 2004;281:35–43.
   PubMed Web of Science ®Google Scholar
• Chaudhary H, Kohli K, Amin S, et al. Optimization and formulation design of gels of diclofenac and curcumin for transdermal drug delivery by Box–Behnken statistical design. J Pharm Sci. 2011;100:580–593.
   PubMed Web of Science ®Google Scholar
• Kute S, Saudagar R. Emulsified gel a novel approach for delivery of hydrophobic drugs: an overview. J Adv Pharm Edu Res. 2013;3:368–376.
   Google Scholar
• Rawat S, Warade S, Lahoti S. In situ gel formulation of ornidazole for the treatment of periodontal disease. Curr Pharma Res. 2010;1:60–69.
   Google Scholar
• El-Nabarawi MA, Ali AA, Aboud HM, et al. Transbuccal delivery of betahistine dihydrochloride from mucoadhesive tablets with a unidirectional drug flow: in vitro, ex vivo and in vivo evaluation. Drug Des Devel Ther. 2016;10:4031.
   PubMed Web of Science ®Google Scholar
• Wu C, Qi H, Chen W, et al. Preparation and evaluation of a carbopol/HPMC-based in situ gelling ophthalmic system for puerarin. Yakugaku Zasshi. 2007;127:183–191.
   PubMed Web of Science ®Google Scholar
• Harish N, Prabhu P, Charyulu R, et al. Formulation and evaluation of in situ gels containing clotrimazole for oral candidiasis. Indian J Pharm Sci. 2009;71:421
   PubMed Web of Science ®Google Scholar
• Khan MA, Kumar S, Sastry J, et al. Analgesic and anti-inflammatory potential of three new topical polyherbal formulations in wistar rats. Ann Phytomed. 2015;4:90–93.
   Web of Science ®Google Scholar
• Morris CJ. Carrageenan-induced paw edema in the rat and mouse. Inflammation Protocols. 2003;225:115–121.
   Google Scholar
• Ma Y, Li Y, Li X, et al. Anti-inflammatory effects of 4-methylcyclopentadecanone on edema models in mice. Int J Mol Sci. 2013;14:23980–23992.
   PubMed Web of Science ®Google Scholar
• Zhang K, Zhang Y, Li Z, et al. Essential oil-mediated glycerosomes increase transdermal paeoniflorin delivery: optimization, characterization, and evaluation in vitro and in vivo. Ijn. 2017;12:3521.
   Google Scholar
• Sharma N, Madan P, Lin S. Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: a co-surfactant study. A J Pharm Sci. 2016;11:404–416.
   Web of Science ®Google Scholar
• Sułkowski W, Pentak D, Nowak K, et al. The influence of temperature, cholesterol content and pH on liposome stability. J Mol Struct. 2005;744–747:737–747.
   Web of Science ®Google Scholar
• Manca ML, Castangia I, Caddeo C, et al. Improvement of quercetin protective effect against oxidative stress skin damages by incorporation in nanovesicles. Colloids Surf B Biointerfaces. 2014;123:566–574.
   PubMed Web of Science ®Google Scholar
• Shen L-N, Zhang Y-T, Wang Q, et al. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharm. 2014;460:280–288.
   PubMed Web of Science ®Google Scholar
• Fang Y-P, Tsai Y-H, Wu P-C, et al. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. Int J Pharm. 2008;356:144–152.
   PubMed Web of Science ®Google Scholar
• Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharm Sin B. 2011;1:208–219.
   Web of Science ®Google Scholar
• Castangia I, Manca ML, Matricardi P, et al. Effect of diclofenac and glycol intercalation on structural assembly of phospholipid lamellar vesicles. Int J Pharm. 2013;456:1–9.
   PubMed Web of Science ®Google Scholar
• Lopes L, Scarpa M, Silva G, et al. Studies on the encapsulation of diclofenac in small unilamellar liposomes of soya phosphatidylcholine. Colloids Surf B Biointerfaces. 2004;39:151–158.
   PubMed Web of Science ®Google Scholar
• Deniz A, Sade A, Severcan F, et al. Celecoxib-loaded liposomes: effect of cholesterol on encapsulation and in vitro release characteristics. Biosci Rep. 2010;30:365–373.
   PubMed Web of Science ®Google Scholar
• Taymouri S, Varshosaz J. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes. Adv Biomed Res. 2016;5:48–62.
   PubMedGoogle Scholar
• Li J, Wang X, Zhang T, et al. A review on phospholipids and their main applications in drug delivery systems. A J Pharm Sci. 2015;10:81–98.
   Web of Science ®Google Scholar
• Salem HF, Kharshoum RM, Abdel Hakim LF, et al. Edge activators and a polycationic polymer enhance the formulation of porous voriconazole nanoagglomerate for the use as a dry powder inhaler. J Liposome Res. 2016;26:324–335.
   PubMed Web of Science ®Google Scholar
• Goyal G, Garg T, Malik B, et al. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv. 2015;22:1027–1042.
   PubMed Web of Science ®Google Scholar
• Elsayed MM, Abdallah OY, Naggar VF, et al. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm. 2006;322:60–66.
   PubMed Web of Science ®Google Scholar
• Kang SN, Hong S-S, Kim S-Y, et al. Enhancement of liposomal stability and cellular drug uptake by incorporating tributyrin into celecoxib-loaded liposomes. A J Pharm Sci. 2013;8:128–133.
   Google Scholar
• Jain S, Jain P, Umamaheshwari R, et al. Transfersomes-a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm. 2003;29:1013–1026.
   PubMed Web of Science ®Google Scholar
• Chawla G, Gupta P, Thilagavathi R, et al. Characterization of solid-state forms of celecoxib. Eur J Pharm Sci. 2003;20:305–317.
   PubMed Web of Science ®Google Scholar
• El-Ridy M, ElRahman AA, Awad G, et al. In-vitro and in-vivo evaluation of niosomes containing celecoxib. Int J Pharm Sci Res. 2014;1:4677.
   Google Scholar
• Begum MY, Abbulu K, Sudhakar M. Celecoxib loaded liposomes: development, characterization and in vitro evaluation. Int J Pharm Sci Res. 2012;3:154.
   Google Scholar
• Lucero M, Vigo J, Leon M. A study of shear and compression deformations on hydrophilic gels of tretinoin. Int J Pharm. 1994;106:125–133.
   Web of Science ®Google Scholar
• Andrews GP, Laverty TP, Jones DS. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm. 2009;71:505–518.
   PubMed Web of Science ®Google Scholar